Variant report

Variant	esv2750987
Chromosome Location	chr11:18887459-18975222
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:201)
CpG islands
(count:367)
Chromatin interactive
region (count:4)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:201 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL11A	chr11:18887554-18887781	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr11:18965116-18965409	K562	blood:	n/a	n/a
3	CEBPB	chr11:18946494-18946596	HepG2	liver:	n/a	chr11:18946576-18946587
4	CEBPB	chr11:18970388-18970535	A549	lung:	n/a	n/a
5	CEBPB	chr11:18943007-18943263	K562	blood:	n/a	n/a
6	CEBPD	chr11:18965149-18965591	K562	blood:	n/a	n/a
7	CEBPD	chr11:18942867-18943456	K562	blood:	n/a	n/a
8	CTCF	chr11:18912305-18912431	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr11:18912319-18912427	MCF-7	breast:	n/a	n/a
10	CTCF	chr11:18973975-18974019	LNCaP	prostate:	n/a	n/a
11	CTCF	chr11:18944088-18944127	GM20000	blood:	n/a	n/a
12	CTCF	chr11:18949160-18949310	HMEC	breast:	n/a	n/a
13	CTCF	chr11:18944630-18944650	GM20000	blood:	n/a	n/a
14	CTCF	chr11:18912260-18912410	Caco-2	colon:	n/a	n/a
15	CTCF	chr11:18912260-18912410	WERI-Rb-1	eye:	n/a	n/a
16	CTCF	chr11:18949130-18949280	K562	blood:	n/a	n/a
17	CTCF	chr11:18912240-18912390	WERI-Rb-1	eye:	n/a	n/a
18	CTCF	chr11:18949220-18949370	HMEC	breast:	n/a	n/a
19	CTCF	chr11:18949160-18949310	NHEK	skin:	n/a	n/a
20	CTCF	chr11:18912340-18912490	HEK293	kidney:	n/a	n/a
21	CTCF	chr11:18912322-18912400	MCF-7	breast:	n/a	n/a
22	CTCF	chr11:18949082-18949341	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr11:18912200-18912350	NHEK	skin:	n/a	n/a
24	CTCF	chr11:18912345-18912389	Hela-S3	cervix:	n/a	n/a
25	CTCF	chr11:18951819-18951855	Fibrobl	skin:	n/a	n/a
26	CTCF	chr11:18949060-18949210	NHEK	skin:	n/a	n/a
27	CTCF	chr11:18912280-18912430	A549	lung:	n/a	n/a
28	CTCF	chr11:18943965-18943999	LNCaP	prostate:	n/a	n/a
29	CTCF	chr11:18915764-18915770	GM10248	blood:	n/a	n/a
30	CTCF	chr11:18949226-18949297	Hela-S3	cervix:	n/a	n/a
31	CTCF	chr11:18912260-18912410	MCF-7	breast:	n/a	n/a
32	CTCF	chr11:18912287-18912437	MCF-7	breast:	n/a	n/a
33	CTCF	chr11:18949100-18949250	RPTEC	kidney:	n/a	n/a
34	CTCF	chr11:18912280-18912430	HepG2	liver:	n/a	n/a
35	CTCF	chr11:18964083-18964146	GM10248	blood:	n/a	n/a
36	CTCF	chr11:18912320-18912470	MCF-7	breast:	n/a	n/a
37	CTCF	chr11:18912387-18912391	GM19239	blood:	n/a	n/a
38	CTCF	chr11:18912302-18912431	MCF-7	breast:	n/a	n/a
39	CTCF	chr11:18912314-18912425	NHEK	skin:	n/a	n/a
40	CTCF	chr11:18949060-18949210	RPTEC	kidney:	n/a	n/a
41	CTCF	chr11:18912320-18912470	Caco-2	colon:	n/a	n/a
42	CTCF	chr11:18952280-18952430	HMF	breast:	n/a	n/a
43	CTCF	chr11:18912140-18912290	HCT-116	colon:	n/a	n/a
44	CTCF	chr11:18973940-18974063	Kidney_OC	kidney:	n/a	n/a
45	CTCF	chr11:18949200-18949350	HEEpiC	esophagus:	n/a	n/a
46	CTCF	chr11:18912305-18912426	MCF-7	breast:	n/a	n/a
47	CTCF	chr11:18912179-18912483	MCF-7	breast:	n/a	n/a
48	CTCF	chr11:18912280-18912430	RPTEC	kidney:	n/a	n/a
49	CTCF	chr11:18949140-18949290	HPAF	blood vessel:	n/a	n/a
50	E2F4	chr11:18957940-18958060	MCF10A-Er-Src	breast:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:18957755-18957805	ECC-1	luminal epithelium:	n/a
2	chr11:18957755-18957805	ECC-1	luminal epithelium:	n/a
3	chr11:18956196-18956246	GM06990	blood:	n/a
4	chr11:18887821-18887871	GM12891	blood:	n/a
5	chr11:18956283-18956333	Hepatocyte	liver:	n/a
6	chr11:18956637-18956687	BE2_C	brain:	n/a
7	chr11:18955977-18956027	HNPCEpiC	eye:	n/a
8	chr11:18887821-18887871	HAEpiC	amniotic membrane:	n/a
9	chr11:18956283-18956333	HUVEC	blood vessel:	n/a
10	chr11:18956283-18956333	Hela-S3	cervix:	n/a
11	chr11:18956283-18956333	T-47D	breast:	n/a
12	chr11:18955977-18956027	GM06990	blood:	n/a
13	chr11:18956283-18956333	CMK	blood:	n/a
14	chr11:18957755-18957805	HUVEC	blood vessel:	n/a
15	chr11:18956196-18956246	GM12878	blood:	n/a
16	chr11:18956196-18956246	SAEC	small airway:	n/a
17	chr11:18956637-18956687	HCT-116	colon:	n/a
18	chr11:18955977-18956027	HRCEpiC	kidney:	n/a
19	chr11:18956283-18956333	NT2-D1	testis:	n/a
20	chr11:18956637-18956687	GM12892	blood:	n/a
21	chr11:18956637-18956687	AG10803	skin:	n/a
22	chr11:18955977-18956027	ProgFib	skin:	n/a
23	chr11:18956196-18956246	H1-hESC	embryonic stem cell:	embryo
24	chr11:18957755-18957805	HL-60	blood:	n/a
25	chr11:18956196-18956246	ECC-1	luminal epithelium:	n/a
26	chr11:18957755-18957805	Caco-2	colon:	n/a
27	chr11:18887821-18887871	HPAEpiC	pulmonary alveolar:	n/a
28	chr11:18956637-18956687	AG09319	gingival:	n/a
29	chr11:18956283-18956333	HIPEpiC	eye:	n/a
30	chr11:18887821-18887871	IMR90	lung:	fetal
31	chr11:18956283-18956333	HCPEpiC	choroid plexus:	n/a
32	chr11:18957755-18957805	HMEC	breast:	n/a
33	chr11:18956196-18956246	K562	blood:	n/a
34	chr11:18957755-18957805	SK-N-SH_RA	brain:	n/a
35	chr11:18955977-18956027	AoSMC	blood vessel:	n/a
36	chr11:18956196-18956246	SKMC	muscle:	n/a
37	chr11:18956637-18956687	HCPEpiC	choroid plexus:	n/a
38	chr11:18956196-18956246	T-47D	breast:	n/a
39	chr11:18955977-18956027	HRPEpiC	eye:	n/a
40	chr11:18887821-18887871	AG04449	skin:	fetal
41	chr11:18956283-18956333	HAEpiC	amniotic membrane:	n/a
42	chr11:18956196-18956246	HCM	heart:	n/a
43	chr11:18955977-18956027	Hepatocyte	liver:	n/a
44	chr11:18956196-18956246	HMEC	breast:	n/a
45	chr11:18957755-18957805	GM12892	blood:	n/a
46	chr11:18887821-18887871	CMK	blood:	n/a
47	chr11:18957755-18957805	K562	blood:	n/a
48	chr11:18955977-18956027	SK-N-SH_RA	brain:	n/a
49	chr11:18956283-18956333	AG10803	skin:	n/a
50	chr11:18957755-18957805	HEEpiC	esophagus:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:18951880..18953861-chr11:18956190..18958282,2	K562	blood:
2	chr11:18898429..18900473-chr11:18904147..18906021,2	K562	blood:
3	chr11:18898429..18900473-chr11:18904147..18906021,2	K562	blood:
4	chr11:18948757..18949726-chr11:19092570..19093333,3	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZDHHC13-2	chr11:18960852-18961268	ENSG00000255244.1
2	lnc-ZDHHC13-2	chr11:18956532-18956821	ENSG00000255244.1

No data

Variant related genes	Relation type
MRGPRX1	TF binding region
ENSG00000254529	TF binding region
ENSG00000255536	TF binding region
ENSG00000254541	TF binding region
ENSG00000255244	TF binding region
ENSG00000255511	TF binding region
MRGPRX1	CpG island
ENSG00000254529	CpG island
ENSG00000255536	CpG island
ENSG00000254541	CpG island
ENSG00000255244	CpG island
ENSG00000255511	CpG island
ENSG00000255244	chromatin interactions
ENSG00000170255	chromatin interactions

Extended variants
information (count: 1861 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:1861 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4325289	chr11:18887459-18887460	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs188306772	chr11:18887475-18887476	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs7931464	chr11:18887478-18887479	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs558948393	chr11:18887492-18887493	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs116485390	chr11:18887518-18887519	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs556995032	chr11:18887534-18887535	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs369590789	chr11:18887544-18887545	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs139047799	chr11:18887615-18887616	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs149449895	chr11:18887619-18887620	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs537481267	chr11:18887643-18887644	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs144144725	chr11:18887648-18887649	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs1483095	chr11:18887681-18887682	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs540521665	chr11:18887702-18887703	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs569345875	chr11:18887713-18887714	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs35258041	chr11:18887725-18887726	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs569788026	chr11:18887749-18887750	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs12225720	chr11:18887751-18887752	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs577063055	chr11:18887766-18887767	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs544431996	chr11:18887777-18887778	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs562412195	chr11:18887788-18887789	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs529821006	chr11:18887790-18887791	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs548010533	chr11:18887794-18887795	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs148701797	chr11:18887806-18887807	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs527337637	chr11:18887812-18887813	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs1483096	chr11:18887813-18887814	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs181076092	chr11:18887825-18887826	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs143482033	chr11:18887844-18887845	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs184147809	chr11:18887857-18887858	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs569378139	chr11:18887887-18887888	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs146734938	chr11:18887897-18887898	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs534992103	chr11:18887917-18887918	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs75065316	chr11:18887980-18887981	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs371488436	chr11:18888001-18888002	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs114726884	chr11:18888023-18888024	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs534184699	chr11:18888043-18888044	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs558852713	chr11:18888103-18888104	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs558008774	chr11:18888107-18888108	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs74985606	chr11:18888137-18888138	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs188812743	chr11:18888156-18888157	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs75441849	chr11:18888175-18888176	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs369053707	chr11:18888180-18888181	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs574581963	chr11:18888211-18888212	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs541900762	chr11:18888310-18888311	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs144314687	chr11:18888349-18888350	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs527240207	chr11:18888360-18888361	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs151056401	chr11:18888366-18888367	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs181648537	chr11:18888458-18888459	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs187056150	chr11:18888584-18888585	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs532643885	chr11:18888614-18888615	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs550896139	chr11:18888650-18888651	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Cancer	21183584	CNVD
Gastric adenocarcinoma	19115996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Multiple myeloma	16461302	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Neuroblastoma	21899760	CNVD
Lung adenocarcinoma	17086460	CNVD
Urothelial cell carcinoma	18451213	CNVD
Lung cancer	17086460	CNVD
Uterine serous papillary cancer	19536090	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Medulloblastoma	16783165	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Ollier disease	21235737	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Ependymoma	20639864	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:113 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:18881800-18899800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr11:18886400-18888600	Enhancers	H1 Cell Line	embryonic stem cell
3	chr11:18886600-18888600	Enhancers	iPS-15b Cell Line	embryonic stem cell
4	chr11:18886800-18887800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr11:18886800-18888200	Enhancers	ES-I3 Cell Line	embryonic stem cell
6	chr11:18886800-18888600	Enhancers	H9 Cell Line	embryonic stem cell
7	chr11:18887000-18887600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
8	chr11:18887000-18888600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
9	chr11:18887200-18887600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
10	chr11:18887200-18887600	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
11	chr11:18887200-18887600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
12	chr11:18887200-18887600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
13	chr11:18887400-18887600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
14	chr11:18887600-18887800	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr11:18887600-18887800	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr11:18887600-18887800	Enhancers	HUES64 Cell Line	embryonic stem cell
17	chr11:18887600-18887800	Enhancers	iPS-20b Cell Line	embryonic stem cell
18	chr11:18887600-18888000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
19	chr11:18887600-18888400	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr11:18887800-18888000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
21	chr11:18887800-18888000	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
22	chr11:18887800-18888000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
23	chr11:18887800-18888600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
24	chr11:18888000-18888400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
25	chr11:18888000-18888400	Enhancers	HUES48 Cell Line	embryonic stem cell
26	chr11:18888000-18888400	Enhancers	HUES64 Cell Line	embryonic stem cell
27	chr11:18888000-18888400	Enhancers	iPS-20b Cell Line	embryonic stem cell
28	chr11:18890200-18890400	Bivalent/Poised TSS	Muscle Satellite Cultured Cells	--
29	chr11:18897400-18897600	Flanking Bivalent TSS/Enh	Left Ventricle	heart
30	chr11:18899600-18900200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr11:18907600-18908000	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
32	chr11:18908000-18908600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr11:18915200-18922000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr11:18918200-18919600	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr11:18918400-18918600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
36	chr11:18919000-18919200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr11:18919200-18919600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr11:18919600-18920400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr11:18919600-18921400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr11:18920400-18921000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr11:18920800-18923000	Enhancers	HepG2	liver
42	chr11:18921000-18921800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr11:18921000-18922200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr11:18921000-18922200	Enhancers	iPS-20b Cell Line	embryonic stem cell
45	chr11:18921200-18922400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr11:18921200-18922400	Enhancers	HMEC	breast
47	chr11:18921200-18922600	Enhancers	NHEK	skin
48	chr11:18921400-18921600	Enhancers	iPS-15b Cell Line	embryonic stem cell
49	chr11:18921400-18921800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr11:18921400-18922400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links